Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2491
-0.0020(-0.16%)
Bitcoin GBP
51,253.50
-576.04(-1.11%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Aveanna Healthcare Holdings Inc. (AVAH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

2.2000

0.0000

(0.00%)

At close: 04:00PM EDT

2.2000

0.00

(0.00%)

After hours:

04:20PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	423.23M
Enterprise value	1.72B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.22
Price/book (mrq)	1.17
Enterprise value/revenue	0.91
Enterprise value/EBITDA	44.00

Trading information

Stock price history

Beta (5Y monthly)	2.04
52-week change ³	78.86%
S&P500 52-week change ³	21.08%
52-week high ³	3.0000
52-week low ³	0.8500
50-day moving average ³	2.3790
200-day moving average ³	2.0034

Share statistics

Avg vol (3-month) ³	94.52k
Avg vol (10-day) ³	74.68k
Shares outstanding ⁵	192.38M
Implied shares outstanding ⁶	202M
Float ⁸	44.9M
% held by insiders ¹	5.75%
% held by institutions ¹	88.35%
Shares short (15 Apr 2024) ⁴	1.04M
Short ratio (15 Apr 2024) ⁴	9.33
Short % of float (15 Apr 2024) ⁴	2.02%
Short % of shares outstanding (15 Apr 2024) ⁴	0.54%
Shares short (prior month 15 Mar 2024) ⁴	1.07M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2023
Most-recent quarter (mrq)	30 Dec 2023

Profitability

Profit margin	-7.10%
Operating margin (ttm)	6.45%

Management effectiveness

Return on assets (ttm)	4.14%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	1.9B
Revenue per share (ttm)	9.98
Quarterly revenue growth (yoy)	6.10%
Gross profit (ttm)	N/A
EBITDA	122.06M
Net income avi to common (ttm)	-134.52M
Diluted EPS (ttm)	-0.7100
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	43.94M
Total cash per share (mrq)	0.23
Total debt (mrq)	1.5B
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.89
Book value per share (mrq)	-0.67

Cash flow statement

Operating cash flow (ttm)	22.67M
Levered free cash flow (ttm)	-11.68M